This is a $48,745.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENQUADFI VIAL 0.5ML, a medical product, with a completion date of February 18, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,054.92 firm-fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office division, is a significant supplier of pharmaceutical products and medical supplies to various U.S. government agencies,...
This is a $45,907.20 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is to provide MENQUADFI VIAL 0.5ML medical supplies, with a completion date of July 1, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which supports military and veteran healthcare programs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor and supplier to the federal government. The $1,404.96 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of July 18, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the procurement of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a potential value of $1,404.96 and a period of performance through January 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA to...
This is a $3,235.37 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENQUADFI VIAL 0.5ML, a medical product, with a period of performance through July 10, 2025. The contract is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $47,337.10 with a firm fixed price, and the ultimate completion date is April 27, 2023. The contract is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $19,312.56 firm fixed price contract is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of June 10, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with significant Indefinite...
This is a $13,049.25 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies and has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received this award as a task order under a larger $999,999,999.00 indefinite delivery contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,109.56, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...